Great development for Biotron. NIAID funding derisks a lot of the preclinical development and showcases the strength of the compound portfolio.
Let's watch and see how the market responds. Hopefully, the Australian picks this up on its business news and maybe a spot on Sky Business for MM.
Strong buy at current price in my view.
Great development for Biotron. NIAID funding derisks a lot of...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(2.56%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $1.388K | 69.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1363438 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 221886 | 2 |
View Market Depth
| Last trade - 14.21pm 06/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |